- Home
- DNTH vs DFH Comparison
DNTH vs DFH Comparison
Compare DNTH & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | DFH |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DNTH | DFH |
|---|---|---|
| Price | $42.09 | $17.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $68.00 | $26.00 |
| AVG Volume (30 Days) | ★ 678.9K | 383.1K |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.84 |
| Revenue | $3,078,000.00 | ★ $4,671,814,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.86 |
| P/E Ratio | ★ N/A | $6.30 |
| Revenue Growth | N/A | ★ 15.98 |
| 52 Week Low | $13.37 | $17.38 |
| 52 Week High | $45.46 | $31.50 |
Technical Indicators
Market Signals| Indicator | DNTH | DFH |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 37.57 |
| Support Level | $42.02 | $17.38 |
| Resistance Level | $44.00 | $17.97 |
| Average True Range (ATR) | 1.76 | 0.70 |
| MACD | -0.27 | -0.07 |
| Stochastic Oscillator | 46.85 | 10.67 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.